RESPICENTRAL(TM)— 510(k) K863538

Substantially Equivalent

Dickstein, Shapiro & Morin

FDA 510(k) clearance K863538 for RESPICENTRAL(TM), Substantially Equivalent on 1986-09-24. Applicant: Dickstein, Shapiro & Morin.

Clearance details

Applicant: Dickstein, Shapiro & Morin
Product code: Code BZK
Advisory panel: Anesthesiology
Date received: 1986-09-11
Decision date: 1986-09-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Washington, DC, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code BZK

product code BZK

Death: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.